Trade Mark Journal No.2026/043 23 October 2026
WO0000001941241 (5)
Office of origin: United States of America
Date of International Registration:23 June 2026
Date of designation in the UK:
23 June 2026

- Class 5
- Chemical preparations for pharmaceutical or medical purposes, namely, for use in modulating disease targets by bringing two proteins together; chemical preparations for pharmaceutical or medical purposes, namely, for for use in modulating disease targets by bringing two proteins together in a noncovalent manner.
Rapafusyn Pharmaceuticals, Inc.
Representative: Erik J. Heels Clocktower Law LLC, PO Box 2920, Acton MA 01720, UNITED STATES OF AMERICA